(Q40197207)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

10

John C Bell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

7

David F Stojdl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

6

Brian D Lichty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Anthony T Power

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Jiahu Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Jennifer M Paterson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Kelley A Parato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Peter A J Forsyth

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Harry Atkins

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

123-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

Recent progress in the battle between oncolytic viruses and tumours

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

The complement response against an oncolytic virus is species-specific in its activation pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Synergistic antitumor effects of immune cell-viral biotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Effective anti-metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with Newcastle disease virus (NDV).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Deformation of red blood cells in capillaries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Chemokine control of lymphocyte trafficking: a general overview.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Glycoviruses: chemical glycosylation retargets adenoviral gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

A monomeric red fluorescent protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300039

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300039

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164783%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference